Alan Lewis Talks About Getting an Embryonic Stem Cell-Based Therapy to Patients
Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is the former president and CEO of Novocell (now ViaCyte), a La Jolla-based company that has been developing a potential therapy for diabetes. Novocell has several CIRM grants to develop a stem cell-based therapy for diabetes. You can see a complete list of their CIRM awards here.
Learn about how CIRM-funded stem cell research could generate treatments for many chronic diseases and injuries.